Tercica
Develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases.
Launch date
Market cap
-
Enterprise valuation
$373m (Public information from Jun 2008)
Brisbane United States (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$21.5m | Series A | ||
$44.0m | Series B | ||
| N/A | $49.5m | IPO | |
$75.0m | Growth Equity VC | ||
| N/A | $8.0m | Growth Equity VC | |
$373m Valuation: $373m | Acquisition | ||
| Total Funding | $149m | ||